Compare AbbVie Inc (ABBV) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs PPG Industries, Inc. — how do they compare? AbbVie Inc trades at $253.95 (market cap $449.91B), while PPG Industries, Inc. trades at $113.82 (market cap $26.80B). The key difference: AbbVie Inc is far larger — about 16.8× PPG Industries, Inc.'s market cap, and AbbVie Inc pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| ABBV | PPG | |
|---|---|---|
Market Cap | $449.91B | $26.80B |
Sector | Health | Basic Materials |
52-Week High | $261.07 | $131.56 |
52-Week Low | $184.85 | $94.34 |
Enterprise Value | $513.38B | $32.90B |
Dividend Yield | 2.72% | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $254.44, showing slight daily weakness but maintaining a bullish technical structure with strong institutional support. The company has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $2.65 exceeding the $2.59 estimate. Revenue growth is accelerating, reaching $61.16B in 2025, while the immunology portfolio (Skyrizi, Rinvoq) successfully offsets Humira declines. Analyst consensus remains strongly positive with 68% buy ratings and a $266.33 price target.
The outlook is constructive with robust pipeline developments and dividend growth, though elevated valuation multiples (P/E 124.83, P/B 245.29) and looming patent cliffs in the 2030s present risks. Net income margin compression from 20.38% in 2022 to 6.9% in 2025 requires monitoring, but strong cash generation ($19.03B operating cash flow) supports continued shareholder returns.
PPG Industries (PPG) trades at $120.22, down 4.08% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings of $1.83 per share, beating estimates, and maintains solid profitability with a net margin of 9.83% and ROE of 21.09%. Recent news highlights innovation in aerospace and marine coatings, including a green chemistry award for SIGMAGLIDE 2390 coating.
The outlook is supported by analyst consensus with a $129.40 price target and 52.63% buy ratings, but risks include volume softness and margin pressure. Earnings growth and sustainability initiatives are key catalysts, though macroeconomic headwinds and competitive pressures remain concerns for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
